133 related articles for article (PubMed ID: 23113686)
41. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
[TBL] [Abstract][Full Text] [Related]
42. Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients.
Dranitsaris G; Phillips P; Rotstein C; Puodziunas A; Shafran S; Garber G; Smaill F; Salit I; Miller M; Williams K; Conly J; Singer J; Ioannou S
Pharmacoeconomics; 1998 May; 13(5 Pt 1):509-18. PubMed ID: 10180750
[TBL] [Abstract][Full Text] [Related]
43. [Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins].
Almirante B; Garnacho-Montero J; Maseda E; Candel FJ; Grau S; Guinea J; Moreno I; Muñoz P; Ruiz-Santana S
Rev Esp Quimioter; 2017 Oct; 30(5):355-367. PubMed ID: 28945064
[TBL] [Abstract][Full Text] [Related]
44. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
45. Caspofungin versus liposomal amphotericin B for treatment of invasive fungal infections or febrile neutropenia.
Zhang J; Gong Y; Wang K; Kong J; Chen Y
Chin Med J (Engl); 2014; 127(4):753-7. PubMed ID: 24534235
[TBL] [Abstract][Full Text] [Related]
46. Empiric antifungal therapy in patients with febrile neutropenia.
Ferrara JJ; MacDougall C; Gallagher JC
Pharmacotherapy; 2011 Apr; 31(4):369-85. PubMed ID: 21449626
[TBL] [Abstract][Full Text] [Related]
47. Initial therapeutic strategy of invasive candidiasis for intensive care unit patients: a retrospective analysis from the China-SCAN study.
Cui N; Wang H; Su L; Qiu H; Li R; Liu D;
BMC Infect Dis; 2017 Jan; 17(1):93. PubMed ID: 28114898
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
Betts R; Glasmacher A; Maertens J; Maschmeyer G; Vazquez JA; Teppler H; Taylor A; Lupinacci R; Sable C; Kartsonis N
Cancer; 2006 Jan; 106(2):466-73. PubMed ID: 16353208
[TBL] [Abstract][Full Text] [Related]
49. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
Epico Project Group
Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
[TBL] [Abstract][Full Text] [Related]
50. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
Bailly S; Leroy O; Azoulay E; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Timsit JF;
J Infect; 2017 Apr; 74(4):408-417. PubMed ID: 28104387
[TBL] [Abstract][Full Text] [Related]
51. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
Maertens JA; Madero L; Reilly AF; Lehrnbecher T; Groll AH; Jafri HS; Green M; Nania JJ; Bourque MR; Wise BA; Strohmaier KM; Taylor AF; Kartsonis NA; Chow JW; Arndt CA; DePauw BE; Walsh TJ;
Pediatr Infect Dis J; 2010 May; 29(5):415-20. PubMed ID: 20431381
[TBL] [Abstract][Full Text] [Related]
52. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
Keating G; Figgitt D
Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
[TBL] [Abstract][Full Text] [Related]
53. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
[No Abstract] [Full Text] [Related]
54. Treatment of invasive candidiasis: between guidelines and daily clinical practice.
Tagliaferri E; Menichetti F
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):685-9. PubMed ID: 25818660
[TBL] [Abstract][Full Text] [Related]
55. Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis.
Chen K; Wang Q; Pleasants RA; Ge L; Liu W; Peng K; Zhai S
BMC Infect Dis; 2017 Feb; 17(1):159. PubMed ID: 28219330
[TBL] [Abstract][Full Text] [Related]
56. [Candidemia and invasive candidiasis in the adult: clinical forms and treatment].
Cervera C
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):483-91. PubMed ID: 22459688
[TBL] [Abstract][Full Text] [Related]
57. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
Rijnders BJ; Cornelissen JJ; Slobbe L; Becker MJ; Doorduijn JK; Hop WC; Ruijgrok EJ; Löwenberg B; Vulto A; Lugtenburg PJ; de Marie S
Clin Infect Dis; 2008 May; 46(9):1401-8. PubMed ID: 18419443
[TBL] [Abstract][Full Text] [Related]
58. Echinocandins versus non-echinocandins for the treatment of invasive candidiasis: A meta-analysis of randomized controlled trials.
Tashiro S; Osa S; Igarashi Y; Watabe Y; Liu X; Enoki Y; Taguchi K; Mayumi T; Miyazaki Y; Takesue Y; Matsumoto K
J Infect Chemother; 2020 Nov; 26(11):1164-1176. PubMed ID: 32620421
[TBL] [Abstract][Full Text] [Related]
59. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
[TBL] [Abstract][Full Text] [Related]
60. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
